FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• ZENPEP (pancrelipase)

Snippet

SUPPL AP for ZENPEP (PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE)